www.chiesigroup.com Guest

Contrary to the global trend in the pharmaceutical industry in general, the Chiesi continues to steadily increase its investments in R&D. The table below shows that in the last two years the increment versus the previous year has been 17.1% and 22%, respectively (see the table below).

The Industrial Scoreboard Report released annually by the European Commission documents the level of R&D investments in a meaningful sample of European industries. In the 2009 edition, Chiesi features as 1st in Italy and 13th in Europe for investments in the pharmaceutical sector.